Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Ceftazidime / Avibactam Treatment vs Better Available Therapy on Mortality of Patients With Infections Caused by Carbapenem-resistant Enterobacteria

NCT04167228 is registered in ClinicalTrials.gov with Maimónides Biomedical Research Institute of Córdoba as lead sponsor.

NCT NCT04167228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04167228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Ceftazidime / Avibactam Treatment vs Better Available Therapy on Mortality of Patients With Infections Caused by Carbapenem-resistant Enterobacteria
Lead sponsor
Maimónides Biomedical Research Institute of Córdoba
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
May 5, 2021
Enrollment
348 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

carbapenem-resistant enterobacteriaceae infection